Question 1

Has Eric Eross received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $778,312 in general payments to Eric Eross across 1,220 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Eric Eross did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Eric Eross come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Biohaven Pharmaceutical Holding Company Ltd.	153	$142,442
Biohaven Pharmaceuticals, Inc.	113	$121,627
Axsome Therapeutics, Inc.	101	$106,812
AbbVie(2 entities)	237	$96,322
Lilly USA, LLC	149	$91,339
Amgen(2 entities)	91	$57,584
Impel Pharmaceuticals Inc.	80	$53,688
Lundbeck LLC	96	$51,763
Teva Pharmaceuticals USA, Inc.	61	$28,309
Pfizer	110	$21,241
Novartis	6	$4,400
Supernus Pharmaceuticals, Inc.	7	$2,542
Scilex Pharmaceuticals Inc.	5	$88
Abbott	2	$32
Upsher-smith Laboratories LLC	2	$29
Tempus AI, Inc	1	$28
Boston Scientific	1	$15
Tonix Medicines, Inc.	1	$15
Nevro Corp.	1	$14
Currax Pharmaceuticals LLC	1	$13
Impel Pharmaceuticals LLC	1	$6
Travere Therapeutics, Inc.	1	$1

Eric Eross

Payments from drug & device makers

Who reported the general payments

How this compares

Other neurology in Phoenix